Documentos relacionados

1. Effects of morphine and P2Y inhibitor amongst patients with acute coronary syndrome: A meta-analysis of comparative studies.
2. Lesson learnt from the new 2020 ESC guidelines on NSTE-ACS: when clinical judgement precedes and overpasses weak recommendations.
3. Modulation and personalization of therapy after acute coronary syndromes: the road to precision.
4. Current Strategies to Guide the Antiplatelet Therapy in Acute Coronary Syndromes.
5. Novel antiplatelet targets in the treatment of acute coronary syndromes.
6. Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study.
7. Independent Predictors of Adverse Cardiovascular Events in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention During Hospitalization.
8. After stent implantation for ACS, ticagrelor monotherapy after <1 mo of DAPT vs. 12 mo of DAPT improved 1-y net clinical benefit.
9. Timing of invasive management of NSTE-ACS: is the time up for early management?
10. Reading 2023 ESC ACS guidelines between the lines: Gaps in evidence in women.